Regulatory Advances in Biosimilars


An FDA analysis of drug prices from 1999 to 2004 found that the discount from generic competition was just 6 percent with one generic competitor, but jumps to 48 percent with two generic competitors, 56 percent with three, 61 percent with four and 67 percent with five generic producers in a market. Within two years of the expiration of the patent for the popular drug Zantac in mid-1997, generic versions accounted for 90 percent of the treatment’s total sales, and the price for patients was about 10 percent of its pre-generic price. European patents on biologic treatments began to expire in 2000, and in April 2006, Sandoz and Biopartners received EMEA approval for the first European Biogenerics, two products containing human growth hormone.



 


    Related Conference of Regulatory Advances in Biosimilars

    February 14-15, 2023

    8th Pharmaceutical Chemistry Conference

    Paris, France
    February 20-21, 2023

    20th Annual Meet on Pharmaceutical Sciences

    Rome, Italy
    March 10-11, 2023

    Global Pharmaceutical and Pharma Industry Conference

    Brussels, Belgium
    March 13-14, 2023

    33rd Annual European Pharma Congress

    Frankfurt, Germany
    March 27-28, 2023

    16th Global Pharmacovigilance & Clinical Trials Summit

    Vancouver, Canada
    April 03-04, 2023

    16th European Biosimilars Congress

    Barcelona, Spain
    April 25-26, 2023

    4th Annual Congress on Antibiotics and Bacterial Infections

    Amsterdam, Netherlands
    May 07-08, 2023

    Advanced-Materials 2023

    Valencia, Spain
    July 25-26, 2023

    36th World Congress on Pharmacology

    Amsterdam, Netherlands
    August 11-12, 2023

    38th World Congress on Pharmacology and Therapeutics

    Singapore City, Singapore
    August 28-29, 2023

    23rd International Pharmaceutical Conference and Expo

    Vancouver, Canada
    September 06-07, 2023

    16th World Drug Delivery Summit

    London, UK
    September 14-15, 2023

    10th international conference on Physiotherapy

    Bangkok, Thailand
    September 27-28, 2023

    3rd World Congress on Rare Diseases & Orphan Drugs

    Amsterdam, Netherlands
    September 27-28, 2023

    8th International Conference on Future Pharma and Innovations

    Amsterdam, Netherlands
    October 09-10, 2023

    20th International Conference on Pharmaceutical Chemistry

    Barcelona, Spain
    October 12-13, 2023

    26th World Congress on Nursing, Pharmacology and Healthcare

    Budapest, Hungary
    November 09-10, 2023

    11th International Conference on Clinical Trials

    London, UK
    November 10-11, 2023

    3rd World Biosimilars & Biologics Congress

    Berlin, Germany
    December 05-06, 2023

    2nd World Congress on Precision and Personalized Medicine

    Zurich, Switzerland

    Regulatory Advances in Biosimilars Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in